Search Within

PANCREATIC CANCER

Tachykinins and their Receptors in Human Malignancies

Journal: Current Drug Targets
Volume: 7,Issue: 8
Page: 1043-1052
Authors: Carla Palma

The NK-1 Receptor is Involved in the Antitumoural Action of L-733,060 and in the Mitogenic Action of Substance P on Human Pancreatic Cancer Cell Lines

Journal: Letters in Drug Design & Discovery
Volume: 3,Issue: 5
Page: 323-329
Authors: Miguel Munoz, Marisa Rosso and Rafael Covenas

FAK and Interacting Proteins as Therapeutic Targets in Pancreatic Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 10
Page: 742-746
Authors: Deniz A. Ucar and Steven N. Hochwald

Molecular Aspects of Stromal-Parenchymal Interactions in Malignant Neoplasms

Journal: Current Molecular Medicine
Volume: 6,Issue: 6
Page: 685-693
Authors: Attila Zalatnai

The Role of Antioxidant Enzymes in the Growth of Pancreatic Carcinoma

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 1
Page: 61-65
Authors: Nazee Jabbari and Joseph J. Cullen

Clinical Experiment of Mutant Herpes Simplex Virus HF10 Therapy for Cancer

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 2
Page: 169-174
Authors: A. Nakao, S. Takeda, S. Shimoyama, H. Kasuya, H. Kimata, O. Teshigahara, M. Sawaki, T. Kikumori, Y. Kodera, T. Nagasaka, F. Goshima, Y. Nishiyama and T. Imai

Design of New Oxazaphosphorine Anticancer Drugs

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 9
Page: 963-978
Authors: Jun Liang, Min Huang, Wei Duan, Xue-Qing Yu and Shufeng Zhou

Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 3
Page: 209-215
Authors: G. Garcea, M. M. Manson, C. P. Neal, C. J. Pattenden, C. D. Sutton, A. R. Dennison and D. P. Berry

Meta Analysis of Advanced Cancer Survival Data Using Lognormal Parametric Fitting: A Statistical Method to Identify Effective Treatment Protocols

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 15
Page: 1533-1544
Authors: S. Qazi, D. DuMez and F. M. Uckun

Molecular Pathogenesis of Pancreatic Cancer: Advances and Challenges

Journal: Current Molecular Medicine
Volume: 7,Issue: 5
Page: 504-521
Authors: Thilo Welsch, Jorg Kleeff and Helmut Friess

Src Family Nonreceptor Tyrosine Kinases as Molecular Targets for Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 7,Issue: 6
Page: 651-659
Authors: Faye M. Johnson and Gary E. Gallick

Molecularly Targeted Therapy for Gastrointestinal Cancer

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 3
Page: 171-193
Authors: Marcus W. Wiedmann and Karel Caca

Small Molecules with EGFR-TK Inhibitor Activity

Journal: Current Drug Targets
Volume: 6,Issue: 3
Page: 259-274
Authors: Joan Albanell and Pere Gascon

Recent Advances in Combined Modality Treatment for Locally Advanced Pancreatic Cancer

Journal: Current Cancer Therapy Reviews
Volume: 1,Issue: 3
Page: 227-237
Authors: Gorkem Aksu, Binnaz Sarper, Cuneyt Ulutin and Hakan Bakkal

Genetically Modified Dendritic Cells for Cancer Immunotherapy

Journal: Current Gene Therapy
Volume: 5,Issue: 6
Page: 619-628
Authors: Antoni Ribas

Src Family Kinases as Regulators of Angiogenesis: Therapeutic Implications

Journal: Current Cancer Therapy Reviews
Volume: 1,Issue: 1
Page: 45-50
Authors: Donald P. Lesslie III and Gary E. Gallick

General Principles of Photodynamic Therapy (PDT) and Gastrointestinal Applications

Journal: Current Pharmaceutical Biotechnology
Volume: 5,Issue: 4
Page: 397-408
Authors: Marcus W. Wiedmann and Karel Caca

Potent Chemopreventive Agents Against Pancreatic Cancer

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 4
Page: 373-384
Authors: Akiyoshi Nishikawa, Fumio Furukawa, In-Seon Lee, Takuji Tanaka and Masao Hirose

Role of Progastrins and Gastrins and Their Receptors in GI and Pancreatic Cancers: Targets for Treatment

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 19
Page: 2345-2358
Authors: William Rengifo-Cam and Pomila Singh

Bombesin-like Peptides: Candidates as Diagnostic and Therapeutic Tools

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 12
Page: 1013-1022
Authors: B. C. Yegen

Cytochrome P450 Gene-directed Enzyme Prodrug Therapy (GDEPT) for Cancer

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 15
Page: 1405-1416
Authors: Ling Chen and David J. Waxman


Mucins in the Diagnosis and Therapy of Pancreatic Cancer

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 18
Page: 1881-1896
Authors: Jenny J. L. Ho

New Aspects of Regulatory Signaling Pathways and Novel Therapies in Pancreatic Cancer

Journal: Current Molecular Medicine
Volume: 8,Issue: 1
Page: 12-37
Authors: Jannis Kountouras, Michael Diamantidis, Georgios Tsapournas and Christos Zavos

Array-Based Approaches for the Identification of Epigenetic Silenced Tumor Suppressor Genes

Journal: Current Genomics
Volume: 9,Issue: 1
Page: 22-24
Authors: Noriyuki Takai and Hisashi Narahara

Current Adjuvant and Targeted Therapies for Pancreatic Adenocarcinoma

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 17
Page: 1674-1683
Authors: Sabrina E. Sanchez and Jose G. Trevino

Cancer Stem Cells: How can we Target them?

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 30
Page: 3171-3184
Authors: Ivan Ischenko, Hendrik Seeliger, Moshe Schaffer, Karl-Walter Jauch and Christiane J. Bruns

Apoptotic Signaling in Pancreatic Cancer – Therapeutic Application (Supplemental Data)

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 2
Page: 122-133
Authors: Felix Ruckert, Christian Pilarsky, Hans-Detlev Saeger and Robert Grutzmann

Recent Advances and Developments in Treatment Strategies Against Pancreatic Cancer

Journal: Current Clinical Pharmacology
Volume: 4,Issue: 2
Page: 102-112
Authors: Rosemary A. Fryer, Christine Galustian and Angus G. Dalgelish

Reactivation of p53 by Novel MDM2 Inhibitors: Implications for Pancreatic Cancer Therapy

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 3
Page: 319-331
Authors: A.S. Azmi, P.A. Philip, A. Aboukameel, Z. Wang, S. Banerjee, S.F. Zafar, A.-S. Goustin, K. Almhanna, D. Yang, F.H. Sarkar and R.M. Mohammad

Roles of Casein Kinase I η and δ in Gastrointestinal Cancers: Potential New Screening Markers and Drug Targets

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 3
Page: 151-157
Authors: Cristina Modak and Jianyuan Chai

Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation

Journal: Current Molecular Medicine
Volume: 9,Issue: 7
Page: 873-886
Authors: Y. Katoh and M. Katoh

Synthesis, Molecular Targets, and Antitumor Activities of Substituted Tetrahydro-1- Oxopyrano[4,3-b][1]Benzopyrans and Nanogels for Drug Delivery

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 8
Page: 864-876
Authors: Elisabeth M. Perchellet, Jean-Pierre H. Perchellet, Chanran K. Ganta, Deryl L. Troyer, Aibin Shi and Duy H. Hua

A Novel Strategy for Advanced Pancreatic Cancer-Progression of Molecular Targeting Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 8
Page: 877-881
Authors: Shinji Osada and Kazuhiro Yoshida

Targeted Inhibition of AKT in Pancreatic Cancer

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 4
Page: 288-295
Authors: Tawnya L. Bowles, Colin Parsons, Diego J. Muilenburg and Richard J. Bold

S100A8/A9 Proteins in Diseases of the Exocrine Pancreas

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 8,Issue: 4
Page: 348-356
Authors: Rainer Ossig and Jurgen Schnekenburger

Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 3
Page: 190-197
Authors: G. Bar-Sela, R. Epelbaum and M. Schaffer

Nitric Oxide and Pancreatic Cancer Pathogenesis, Prevention, and Treatment

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 4
Page: 421-427
Authors: Liwei Wang and Keping Xie

Novel Therapies Against Aggressive and Recurrent Epithelial Cancers by Molecular Targeting Tumor- and Metastasis-Initiating Cells and Their Progenies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 2
Page: 137-151
Authors: Murielle Mimeault and Surinder K. Batra

In Vitro and In Vivo Antitumor Efficacy of Docetaxel and Sorafenib Combination in Human Pancreatic Cancer Cells

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 6
Page: 600-610
Authors: P. Ulivi, C. Arienti, W. Zoli, M. Scarsella, S. Carloni, F. Fabbri, A. Tesei, E. Chiadini, A. Orlandi, D. Passeri, G. Zupi, C. Milandri, R. Silvestrini, D. Amadori and C. Leonetti

Tyrosine Kinase Inhibitors

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 5
Page: 462-483
Authors: C. Natoli, B. Perrucci, F. Perrotti, L. Falchi and S. Iacobelli

Intraductal Papillary Mucinous Neoplasm (IPMN): A Precursor to Pancreatic Cancer

Journal: Current Cancer Therapy Reviews
Volume: 6,Issue: 3
Page: 175-184
Authors: Albrecht Neesse, Patrick Michl, Marc Kalinowski, Peter J. Barth, Detlef K. Bartsch, Volker Ellenrieder and Thomas M. Gress

Chemical Analysis of the Chinese Herbal Medicine Turmeric (Curcuma longa L.)

Journal: Current Pharmaceutical Analysis
Volume: 6,Issue: 4
Page: 256-268
Authors: Rui Li, Cheng Xiang, Xing Zhang, De- An Guo and Min Ye

Targeting the Resistance of Pancreatic Cancer Cells to Nutrient Deprivation: Anti-Austerity Compounds

Journal: Current Drug Delivery
Volume: 7,Issue: 5
Page: 355-369
Authors: Jakob Magolan and Mark J. Coster

Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors

Journal: Current Drug Delivery
Volume: 8,Issue: 1
Page: 11-25
Authors: Andrew V. Schally, Jorg B. Engel, Gunter Emons, Norman L. Block and Jacek Pinski

Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 3
Page: 254-284
Authors: B. C. Potts, M. X. Albitar, K. C. Anderson, S. Baritaki, C. Berkers, B. Bonavida, J. Chandra, D. Chauhan, J. C. Cusack, W. Fenical, I. M. Ghobrial, M. Groll, P. R. Jensen, K. S. Lam, G. K. Lloyd, W. McBride, D. J. McConkey, C. P. Miller, S. T.C. Neuteboom, Y. Oki, H. Ovaa, F. Pajonk, P. G. Richardson, A. M. Roccaro, C. M. Sloss, M. A. Spear, E. Valashi, A. Younes and M. A. Palladino

Genetic and Epigenetic Alterations in Pancreatic Carcinogenesis

Journal: Current Genomics
Volume: 12,Issue: 1
Page: 15-24
Authors: Yannick Delpu, Naima Hanoun, Hubert Lulka, Flavie Sicard, Janick Selves, Louis Buscail, Jerome Torrisani and Pierre Cordelier

INNO-206 (DOXO-EMCH), an Albumin-Binding Prodrug of Doxorubicin Under Development for Phase II Studies

Journal: Current Bioactive Compounds
Volume: 7,Issue: 1
Page: 33-38
Authors: F. Kratz

Transforming Growth Factor Beta in Pancreatic Cancer

Journal: Current Pharmaceutical Biotechnology
Volume: 12,Issue: 12
Page: 2158-2164
Authors: Andreas Hilbig and Helmut Oettle

Role of the RAS in Pancreatic Cancer

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 4
Page: 412-420
Authors: S. T. Lau and P. S. Leung

Editorial [Hot Topic: Emerging Therapeutic Targets and Agents for Pancreatic Cancer Therapy (Guest Editor: Dr. Felix Ruckert)]

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 5
Page: 408-410
Authors: Susanne Sebens and Holger Kalthoff

Combination Therapy for the Treatment of Pancreatic Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 5
Page: 418-426
Authors: William Greenhalf and Amy Thomas

Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 5
Page: 427-433
Authors: Simon Rieder, Christoph W. Michalski, Helmut Friess and > Kleeff

Aptamers: Potential Applications to Pancreatic Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 5
Page: 434-441
Authors: Kristy L. Rialon and Rebekah R. White

Genes Associated with Epithelial-Mesenchymal Transition: Possible Therapeutic Targets in Ductal Pancreatic Adenocarcinoma?

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 5
Page: 448-454
Authors: Hubert G. Hotz, Birgit Hotz and Heinz-Johannes Buhr

Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer – from Molecular Signalling to Clinical Trials

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 5
Page: 455-463
Authors: Marco Falasca, Federico Selvaggi, Richard Buus, Sara Sulpizio and Charlotte E. Edling

Anti-Angiogenic Agents in Pancreatic Cancer: A Review

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 5
Page: 464-469
Authors: Murwarid M. Assifi and Oscar J. Hines

Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 5
Page: 470-478
Authors: Nicholas J. Zyromski and Patrick B. White

Mechanism of Anti-Tumor Effect by Curcumin in Hematological Malignancies

Journal: Current Pharmaceutical Analysis
Volume: 7,Issue: 2
Page: 120-124
Authors: YI Sha and Chen Yan

Molecular Targeted Approaches for Treatment of Pancreatic Cancer

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 21
Page: 2221-2238
Authors: Z.Q. Huang, A.K. Saluja, V. Dudeja, S.M. Vickers and D.J. Buchsbaum

Novel Approaches to Target Pancreatic Cancer

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 6
Page: 698-713
Authors: M. Porzner and T. Seufferlein

Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 6
Page: 734-751
Authors: P. Goedegebuure, J. B. Mitchem, M. R. Porembka, M. C.B. Tan, B. A. Belt, A. Wang-Gillam, W. E. Gillanders, W. G. Hawkins and D. C. Linehan

The Use of Specific Monoclonal Antibodies to Target Immunogenic Tumor Membrane Proteins in Patients with Recurrent Pancreatic and Colon Cancer

Journal: Current Drug Delivery
Volume: 9,Issue: 1
Page: 52-56
Authors: Myron Arlen, XuePing Wang, Janos Luka, Rishab Gupta, Olga Saric and Philip M. Arlen

Safety of Dipeptidyl Peptidase 4 Inhibitors for Treatment of Type 2 Diabetes

Journal: Current Drug Safety
Volume: 6,Issue: 5
Page: 304-309
Authors: Nasser Mikhail

The Impact of the Activated Stroma on Pancreatic Ductal Adenocarcinoma Biology and Therapy Resistance

Journal: Current Molecular Medicine
Volume: 12,Issue: 3
Page: 288-303
Authors: Mert Erkan, Carolin Reiser-Erkan, Christoph W. Michalski, Bo Kong, Irene Esposito, Helmut Friess and Jorg Kleeff

Genomic Sequencing of Key Genes in Mouse Pancreatic Cancer Cells

Journal: Current Molecular Medicine
Volume: 12,Issue: 3
Page: 331-341
Authors: Y. Wang, Y. Zhang, J. Yang, X. Ni, S. Liu, Z. Li, S. E. Hodges, W. E. Fisher, F. C. Brunicardi, R. A. Gibbs, M.-C. Gingras and M. Li

Inflammation and Pancreatic Cancer: Recent Development with Focusing on Potential New Drug Targets

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 10,Issue: 5
Page: 351-357
Authors: Generoso Uomo, Luigi Laghi and Raffaele Pezzilli

Targeting Prenylated RAS Modifying Enzymes in Cancer Cells

Journal: Current Signal Transduction Therapy
Volume: 1,Issue: 3
Page: 285-293
Authors: Yulong L. Chen

The Effects of All-Trans-Retinoic Acid on Cell Cycle and Alkaline Phosphatase Activity in Pancreatic Cancer Cells

Journal: Medicinal Chemistry
Volume: 2,Issue: 5
Page: 457-461
Authors: J. M. Guo, B. X. Xiao, Y. R. Lou, D. H. Wang, C. H. Yan, L. Zhan and W. H. Zhao

Molecular Targeting in Pancreatic Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 1
Page: 69-75
Authors: Scott Wadler

Back to the Future: COX-2 Inhibitors for Chemoprevention and Cancer Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 6
Page: 599-608
Authors: Fazlul H. Sarkar, Shreelekha Adsule, Yiwei Li and Subhash Padhye

The Biology of Cholecystokinin and Gastrin Peptides

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 12
Page: 1154-1165
Authors: Jens F. Rehfeld, Lennart Friis-Hansen, Jens P. Goetze and Thomas V. O. Hansen

Strategies for the Design of Non-peptide CCK2 Receptor Agonist and Antagonist Ligands

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 12
Page: 1195-1204
Authors: S. Barret Kalindjian and Iain M. McDonald

Compositions for Treatment of Cancer and Inflammation

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 3,Issue: 1
Page: 55-62
Authors: Nadir Arber, Shahar Lev-Ari and Dov Lichtenberg

Clinico-Pathologic and Biologic Predictors of EGFR Inhibitors Activity and Efficacy in Lung and in Colorectal Cancer

Journal: Current Signal Transduction Therapy
Volume: 3,Issue: 3
Page: 234-243
Authors: Maria Anna Bareschino, Clorinda Schettino, Linda Alvino, Cesare Gridelli and Fortunato Ciardiello

Clinical Trials of Targeted Alpha Therapy for Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 3,Issue: 3
Page: 185-191
Authors: Barry J. Allen

Exploiting Apoptosis Pathways for the Treatment of Pancreatic Cancer

Journal: Current Signal Transduction Therapy
Volume: 4,Issue: 1
Page: 1-5
Authors: Simone Fulda

Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4,Issue: 2
Page: 174-179
Authors: Anil Kamath, Dal Yoo, Oswald A. Stuart, Lana Bijelic and Paul H. Sugarbaker

Design, Synthesis, Crystal Structure and Antitumor Activity of A New Ethyl 3-(quinazolin-4-ylamino)-1H-pyrrole-2-carboxylate Derivative

Journal: Letters in Drug Design & Discovery
Volume: 6,Issue: 7
Page: 538-541
Authors: Youguang Zheng, Xiaoqing Wu, Min Sun, Liuhai Feng, Mingdong Li and Min Ji

The Potential use of Dendritic Cell-based Immunotherapy for Treatment of Pancreatic Cancer

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 9,Issue: 4
Page: 191-202
Authors: Mohamed Labib Salem

Tetrac-Conjugated Quantum Dots for Diagnosis and Treatment of Pancreatic Cancer: An In Vitro Evaluation

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 9,Issue: 4
Page: 219-223
Authors: Dhruba J. Bharali, Usawadee Dier, Paul J. Davis and Shaker A. Mousa

What Else in Gemcitabine-Pretreated Advanced Pancreatic Cancer? An Update of Second Line Therapies

Journal: Reviews on Recent Clinical Trials
Volume: 5,Issue: 1
Page: 43-56
Authors: Fausto Petrelli, Karen Borgonovo, Mara Ghilardi, Mary Cabiddu and Sandro Barni

MDM2 Inhibitors for Pancreatic Cancer Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 10,Issue: 6
Page: 518-526
Authors: A.S. Azmi, P.A. Philip, K. Almhanna, F.W. Beck, Z.K. Kafri, F.H. Sarkar and R.M. Mohammad

History of Autoimmune Pancreatitis and Mikuliczs Disease

Journal: Current Immunology Reviews
Volume: 7,Issue: 2
Page: 137-143
Authors: Shigeyuki Kawa and Susumu Sugai

Autoimmune Pancreatitis and Diagnostic Criteria

Journal: Current Immunology Reviews
Volume: 7,Issue: 2
Page: 144-161
Authors: Shigeyuki Kawa, Yasunari Fujinaga, Masao Ota, Hideaki Hamano and Seiamak Bahram

Radiologic Findings of IgG4-Related Disease

Journal: Current Immunology Reviews
Volume: 7,Issue: 2
Page: 186-203
Authors: Yasunari Fujinaga, Masumi Kadoya, Hideaki Hamano, Shigeyuki Kawa, Mitsuhiro Momose, Satoshi Kawakami, Tomoharu Watanabe, Yukiko Sugiyama and Takeshi Uehara

Application of Bioinformatics for the Search of Novel Anti-Viral Therapies: Rational Design of Anti-Herpes Agents

Journal: Current Bioinformatics
Volume: 6,Issue: 1
Page: 81-93
Authors: Alejandro Speck-Planche and M. Natalia D.S. Cordeiro

Design, Synthesis of Novel Quinazolone Alkaloids Derivatives as Potential Antitumor Agents

Journal: Medicinal Chemistry
Volume: 7,Issue: 4
Page: 295-300
Authors: Youguang Zheng, Min Sun, Yi Liu, Mingdong Li and Min Ji

Human Retinoblastoma Binding Protein 9, a Serine Hydrolase Implicated in Pancreatic Cancers

Journal: Protein & Peptide Letters
Volume: 19,Issue: 2
Page: 194-197
Authors: Sergey M. Vorobiev, Yuanpeng Janet Huang, Jayaraman Seetharaman, Rong Xiao, Thomas B. Acton, Gaetano T. Montelione and Liang Tong

Structure-Based Design of Novel Anti-Cancer Agents TargetingAurora Kinases

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3,Issue: 1
Page: 25-34
Authors: Daruka Mahadevan, David J. Bearss and Hariprasad Vankayalapati

Discovery and Advancement of Farnesyl Transferase Inhibitors as Potential Anticancer Therapeutic Agents: SCH 66336 a Case Study

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 1,Issue: 2
Page: 185-198
Authors: F. George Njoroge and Viyyoor M. Girijavallabhan

Recent Patents Concerning Diagnostic and Therapeutic Applications of Aberrantly Methylated Sequences in Pancreatic Cancer

Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 2,Issue: 2
Page: 97-106
Authors: Diana Wehrum, Robert Grutzmann, Mario Hennig, Hans-Detlev Saeger and Christian Pilarsky

A Brief Evaluation of Tumor Imaging in Mice with 99mTc-glucarate Including a Comparison with 18F-FDG

Journal: Current Radiopharmaceuticals
Volume: 4,Issue: 1
Page: 5-9
Authors: Donald Hnatowich, Xinrong Liu, Guozheng Liu, Yuzhen Wang, Yuxia Liu, Dengfeng Cheng and Mary Rusckowski

Recent Patents Concerning Targeted Therapy of Apoptosis Resistance in Pancreatic Cancer

Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 5,Issue: 1
Page: 28-34
Authors: Kristin Werner, Felix Ruckert, Hans-Detlev Saeger, Robert Grutzmann and Christian Pilarsky

Pancreatic Cancer and Personalized Medicine: Can Genomics Facilitate Early Diagnosis or Improve Therapeutic Outcomes?

Journal: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)
Volume: 8,Issue: 1
Page: 73-88
Authors: A. S. Strimpakos, C. Hoimes, K. N. Syrigos and M. W. Saif

An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 4
Page: 439-452
Authors: Nicola Tinari, Michele De Tursi, Antonino Grassadonia, Marinella Zilli, Liborio Stuppia, Stefano Iacobelli and Clara Natoli

Editorial [Hot Topic: Targeted Therapies for Pancreatic Cancer Executive (Guest Editor: Qingyong Ma)]

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 17
Page: 2393-2394
Authors: Qingyong Ma

Therapeutic Potential of Perineural Invasion, Hypoxia and Desmoplasia in Pancreatic Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 17
Page: 2395-2403
Authors: Han Liu, Qingyong Ma, Qinhong Xu, Jianjun Lei, Xuqi Li, Zheng Wang and Erxi Wu

Targeting the Cancer-Stroma Interaction: A Potential Approach for Pancreatic Cancer Treatment

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 17
Page: 2404-2415
Authors: Xuqi Li, Qingyong Ma, Qinhong Xu, Wanxing Duan, Jianjun Lei and Erxi Wu

Cytokine Network: New Targeted Therapy for Pancreatic Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 17
Page: 2416-2419
Authors: Yoichi Matsuo, Hiromitsu Takeyama and Sushovan Guha

Sp/KLF Family and Tumor Angiogenesis in Pancreatic Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 17
Page: 2420-2431
Authors: Weihua Jiang, Jiujie Cui, Dacheng Xie and Liwei Wang

Molecular Mechanisms of Pancreatic Cancer Dissemination: The Role of the Chemokine System

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 17
Page: 2432-2438
Authors: Federica Marchesi, Fabio Grizzi, Luigi Laghi, Alberto Mantovani and Paola Allavena

Advances in Biomarker Research for Pancreatic Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 17
Page: 2439-2451
Authors: Kruttika Bhat, Fengfei Wang, Qingyong Ma, Qinyu Li, Sanku Mallik, Tze-chen Hsieh and Erxi Wu

Novel Therapeutic Approaches in Pancreatic Cancer Based on Genomic Alterations

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 17
Page: 2452-2463
Authors: Shinichi Yachida

Role of Wnt/β-catenin Signaling in Drug Resistance of Pancreatic Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 17
Page: 2464-2471
Authors: Jiujie Cui, Weihua Jiang, Shuyi Wang, Liwei Wang and Keping Xie

Mucin-based Targeted Pancreatic Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 17
Page: 2472-2481
Authors: Maria P. Torres, Subhankar Chakraborty, Joshua Souchek and Surinder K. Batra

Editorial [Hot Topic: Pancreatic Cancer: Between Bench and Bedside (Guest Editors: Davide Melisi and Alfredo Budillon)]

Journal: Current Drug Targets
Volume: 13,Issue: 6
Page: 729-730
Authors: Davide Melisi and Alfredo Budillon

Molecular and Genetic Bases of Pancreatic Cancer

Journal: Current Drug Targets
Volume: 13,Issue: 6
Page: 731-743
Authors: Vanja Vaccaro, Alain Gelibter, Emilio Bria, Pierluigi Iapicca, Paola Cappello, Francesca Di Modugno, Maria Simona Pino, Carmen Nuzzo, Francesco Cognetti, Francesco Novelli, Paola Nistico and Michele Milella

Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation

Journal: Current Drug Targets
Volume: 13,Issue: 6
Page: 744-752
Authors: Vincenzo Corbo, Giampaolo Tortora and Aldo Scarpa

Is Preoperative Endoscopic Biliary Drainage Indicated for Jaundiced Patients with Resectable Pancreatic Cancer?

Journal: Current Drug Targets
Volume: 13,Issue: 6
Page: 753-763
Authors: Mario de Bellis, Raffaele Palaia, Claudia Sandomenico, Elena Di Girolamo, Marco Cascella and Francesco Fiore

Pancreatic Cancer Surgery: The State of the Art

Journal: Current Drug Targets
Volume: 13,Issue: 6
Page: 764-771
Authors: Song Cheol Kim, Young Hoon Kim, Kwang Min Park and Young Ju Lee

Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreas

Journal: Current Drug Targets
Volume: 13,Issue: 6
Page: 781-788
Authors: Robert A. Wolff

Evidences and Opinions for Adjuvant Therapy in Pancreatic Cancer

Journal: Current Drug Targets
Volume: 13,Issue: 6
Page: 789-794
Authors: Michele Reni

Conventional Chemotherapy of Advanced Pancreatic Cancer

Journal: Current Drug Targets
Volume: 13,Issue: 6
Page: 795-801
Authors: Francesco Giuliani, Massimo Di Maio, Giuseppe Colucci and Francesco Perrone

Targeting EGFR in Pancreatic Cancer Treatment

Journal: Current Drug Targets
Volume: 13,Issue: 6
Page: 802-810
Authors: T. Troiani, E. Martinelli, A. Capasso, F. Morgillo, Michele Orditura, F. De Vita and F. Ciardiello

Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics

Journal: Current Drug Targets
Volume: 13,Issue: 6
Page: 811-828
Authors: Ross A. Soo, Wei-Peng Yong and Federico Innocenti

Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 22
Page: 3664-3678
Authors: N. B. Janakiram, A. Mohammed, M. S. Bronze and C. V. Rao

Early Detection and Prevention of Pancreatic Cancer: Use of Genetically Engineered Mouse Models and advanced Imaging Technologies

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 22
Page: 3701-3713
Authors: A. Mohammed, N. B. Janakiram, S. Lightfoot, H. Gali, A. Vibhudutta and C. V. Rao

Expression of Specificity Protein Transcription Factors in Pancreatic Cancer and their Association in Prognosis and Therapy

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 22
Page: 3779-3786
Authors: Umesh T. Sankpal, Pius Maliakal, Debashish Bose, Omar Kayaleh, Daniel Buchholz and Riyaz Basha

Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials

Journal: Current Angiogenesis (Discontinued)
Volume: 1,Issue: 3
Page: 169-179
Authors: Benjamin Schmidt, Hae-June Lee, Sandra Ryeom and Sam S. Yoon

MicroRNAs and Pancreatic Cancer: Current Research and Future Outlooks

Journal: Current Signal Transduction Therapy
Volume: 7,Issue: 3
Page: 305-307
Authors: Wei Li, Kei Satoh, Drake G. LeBrun and Min Li

Therapeutic Targeting of Apoptotic Pathways: Novel Aspects in Pancreatic Cancer

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 11
Page: 2273-2282
Authors: A. Neesse, T.M. Gress and P. Michl

A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 7
Page: 791-800
Authors: Koshi Kawakami, Miho Hattori, Takatsugu Inoue, Yuriko Maruyama, Junko Ohkanda, Nobuo Kato, Miki Tongu, Takaya Yamada, Miho Akimoto, Keizo Takenaga, Takeshi Sassa, Junji Suzumiy and Yoshio Honma

Effect of Low Molecular Weight Heparins and Fondaparinux Upon Thrombin Generation Triggered by Human Pancreatic Cancer Cells BXPC3

Journal: Current Vascular Pharmacology
Volume: 12,Issue: 6
Page: 893-902
Authors: Grigoris T. Gerotziafas, Vassiliki Galea, Elisabeth Mbemba, Mouna Sassi, Marie-Paule Roman, Amir Khaterchi, Patrick van Dreden, Max Japcowitz, Jean Pierre Lotz, Jean Francois Bernaudin, Jawed Fareed, Mohamed Hatmi and Ismail Elalamy

No miR Quirk: Dysregulation of microRNAs in Pancreatic Ductal Adenocarcinoma

Journal: MicroRNA
Volume: 1,Issue: 1
Page: 49-58
Authors: Philip Y. Cheung, Anna E. Szafranska-Schwarzbach, Annette M. Schlageter, Bernard F. Andruss and Glen J. Weiss

Shedding Light on Serum Vitamin D Concentrations and the Risk of Rarer Cancers

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 65-69
Authors: Kathy J. Helzlsouer and Lisa Gallicchio

Genistein Inhibits Cell Growth and Induces Apoptosis Through Up-regulation of miR-34a in Pancreatic Cancer Cells

Journal: Current Drug Targets
Volume: 13,Issue: 14
Page: 1750-1756
Authors: Jun Xia, Qiaoling Duan, Aamir Ahmad, Bin Bao, Sanjeev Banerjee, Ying Shi, Jia Ma, Jian Geng, Zhiwen Chen, KM Wahidur Rahman, Lucio Miele, Fazlul H Sarkar and Zhiwei Wang

Baicalein - An Intriguing Therapeutic Phytochemical in Pancreatic Cancer

Journal: Current Drug Targets
Volume: 13,Issue: 14
Page: 1772-1776
Authors: Graham Donald, Kathleen Hertzer and Guido Eibl

Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 5
Page: 940-950
Authors: Amir Avan, Karl Quint, Francesco Nicolini, Niccola Funel, Adam E. Frampton, Mina Maftouh, Serena Pelliccioni, Gerrit J. Schuurhuis, Godefridus J. Peters and Elisa Giovannetti

BRCA2 Dysfunction Promotes Malignant Transformation of Pancreatic Intraepithelial Neoplasia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 2
Page: 261-269
Authors: Qi Wang, Hongrui Liu, Tingting liu, Shizhen Shu, He Jiang, Shidan Cheng, Yaozong Yuan, Weiguo Yang and Lifu Wang

The Role of Mesothelin in Tumor Progression and Targeted Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 2
Page: 276-280
Authors: Zhewei Tang, Min Qian and Mitchell Ho

The Clinical Utility of CA 19-9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates

Journal: Current Molecular Medicine
Volume: 13,Issue: 3
Page: 340-351
Authors: K. E. Poruk, D. Z. Gay, K. Brown, J. D. Mulvihill, K. M. Boucher, C. L. Scaife, M. A. Firpo and S. J. Mulvihill

Up-Regulation of MBD1 Promotes Pancreatic Cancer Cell Epithelial-Mesenchymal Transition and Invasion by Epigenetic Down-Regulation of E-Cadherin

Journal: Current Molecular Medicine
Volume: 13,Issue: 3
Page: 387-400
Authors: J. Xu, W. Zhu, W. Xu, W. Yao, B. Zhang, Y. Xu, S. Ji, C. Liu, J. Long, Q. Ni and X. Yu

Gene Profile Identifies Zinc Transporters Differentially Expressed in Normal Human Organs and Human Pancreatic Cancer

Journal: Current Molecular Medicine
Volume: 13,Issue: 3
Page: 401-409
Authors: J. Yang, Y. Zhang, X. Cui, W. Yao, X. Yu, P. Cen, S. E. Hodges, W. E. Fisher, F. C. Brunicardi, C. Chen, Q. Yao and M. Li

Selective Induction of Apoptosis: Promising Therapy in Pancreatic Cancer

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 12
Page: 2259-2268
Authors: Zuojia Liu, Dan Li, Xiliang Zheng, Erkang Wang and Jin Wang

Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13,Issue: 4
Page: 530-540
Authors: Tina Sharma, Richa Dhingra, Sukhminder Singh, Shivani Sharma, Prince Tomar, Manav Malhotra and T. R. Bhardwaj

Inhibiting the Interaction of cMET and IGF-1R with FAK Effectively Reduces Growth of Pancreatic Cancer Cells in vitro and in vivo

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 4
Page: 595-602
Authors: Deniz A. Ucar, Andrew T. Magis, Di-Hua He, Nicholas J. Lawrence, Said M. Sebti, Elena Kurenova, Maria Zajac-Kaye, Jianliang Zhang and Steven N. Hochwald

MicroRNA-34b Inhibits Pancreatic Cancer Metastasis Through Repressing Smad3

Journal: Current Molecular Medicine
Volume: 13,Issue: 4
Page: 467-478
Authors: C. Liu, H. Cheng, S. Shi, X. Cui, J. Yang, L. Chen, P. Cen, X. Cai, Y. Lu, C. Wu, W. Yao, Y. Qin, L. Liu, J. Long, J. Xu, M. Li and X. Yu

Radiofluorinated Carbohydrates for Positron Emission Tomography

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 8
Page: 944-950
Authors: Jiyoung Mun

Therapeutic Perspectives on Pancreatic Cancer

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 4
Page: 400-410
Authors: Anjali V. Sheahan, Phoebe A. Phillips and Levon M. Khachigian

Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 4
Page: 460-471
Authors: Alessandra Dicitore, Michele Caraglia, Annamaria Colao, Silvia Zappavigna, Daniela Mari, Leo J. Hofland, Luca Persani and Giovanni Vitale

Cucurmosin Kills Human Pancreatic Cancer SW-1990 Cells in vitro and in vivo

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 6
Page: 952-956
Authors: Jieming Xie, Congfei Wang, Aiqin Yang, Baoming Zhang, Qiang Yin, Heguang Huang and Minghuang Chen

An N-terminally Truncated Mutant of Human Chemokine CXCL14 has Biological Activity

Journal: Protein & Peptide Letters
Volume: 20,Issue: 8
Page: 955-967
Authors: Jose L. Neira, María J. Sandí, Julio Bacarizo, Cendrine Archange, Ana Camara- Artigas and Juan L. Iovanna

Inhibition of Hedgehog/Gli Signaling by Botanicals: A Review of Compounds with Potential Hedgehog Pathway Inhibitory Activities

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 5
Page: 580-595
Authors: Sara K. Drenkhahn, Glenn A. Jackson, Anna Slusarz, Nicholas J.E. Starkey and Dennis B. Lubahn

β2-AR-HIF-1α: A Novel Regulatory Axis for Stress-Induced Pancreatic Tumor Growth and Angiogenesis

Journal: Current Molecular Medicine
Volume: 13,Issue: 6
Page: 1023-1034
Authors: T. Shan, J. Ma, Q. Ma, K. Guo, J. Guo, X. Li, W. Li, J. Liu, C. Huang, F. Wang and E. Wu

Validated RP-HPLC Method for the Simultaneous Analysis of Gemcitabine and LY-364947 in Liposomal Formulations

Journal: Current Drug Targets
Volume: 14,Issue: 9
Page: 1061-1069
Authors: Shyam S. Bansal, Christian Celia, Silvia Ferrati, Erika Zabre, Mauro Ferrari, Ganesh Palapattu and Alessandro Grattoni

Chemoprevention Gene Therapy (CGT): Novel Combinatorial Approach for Preventing and Treating Pancreatic Cancer

Journal: Current Molecular Medicine
Volume: 13,Issue: 7
Page: 1140-1159
Authors: S. Sarkar, B. M. Azab, S. K. Das, B. A. Quinn, X. Shen, R. Dash, L. Emdad, S. Thomas, S. Dasgupta, Z.-Z. Su, X.-Y. Wang, D. Sarkar and P. B. Fisher

Aspirin: A Potential Therapeutic Approach in Pancreatic Cancer

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 33
Page: 4153-4162
Authors: Xin Shen, Liang Han, Zhenhua Ma, Chao Chen, Wanxing Duan, Shuo Yu, Pei Li, Lun Zhang, Wei Li, Qinhong Xu and Qingyong Ma

Prospects of miRNA-Based Therapy for Pancreatic Cancer

Journal: Current Drug Targets
Volume: 14,Issue: 10
Page: 1101-1109
Authors: Priya Pai, Satyanarayana Rachagani, Chandrakanth Are and Surinder K. Batra

miRNAs in Insulin Resistance and Diabetes-Associated Pancreatic Cancer: The ‘Minute and Miracle’ Molecule Moving as a Monitor in the ‘Genomic Galaxy’

Journal: Current Drug Targets
Volume: 14,Issue: 10
Page: 1110-1117
Authors: Chiranjib Chakraborty, George Priya Doss. C and Sanghamitra Bandyopadhyay

Genistein Down-Regulates miR-223 Expression in Pancreatic Cancer Cells

Journal: Current Drug Targets
Volume: 14,Issue: 10
Page: 1150-1156
Authors: Jia Ma, Long Cheng, Hao Liu, Jing Zhang, Ying Shi, Fanpeng Zeng, Lucio Miele, Fazlul H Sarkar, Jun Xia and Zhiwei Wang

Profilin1 Sensitizes Pancreatic Cancer Cells to Irradiation by Inducing Apoptosis and Reducing Autophagy

Journal: Current Molecular Medicine
Volume: 13,Issue: 8
Page: 1368-1375
Authors: H. Cheng, J. Li, C. Liu, W. Yao, Y. Xu, T. S. Frank, X. Cai, S. Shi, Y. Lu, Y. Qin, L. Liu, J. Xu, J. Long, Q.-X. Ni, M. Li and X.-J. Yu

MET As a Potential Target for the Treatment of Upper Gastrointestinal Cancers: Characterization of Novel c-Met Inhibitors from Bench to Bedside

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 8
Page: 975-989
Authors: A. Avan, M. Maftouh, N. Funel, M. Ghayour-Mobarhan, U. Boggi, G.J. Peters and E. Giovannetti

Target Therapies in Pancreatic Carcinoma

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 8
Page: 948-965
Authors: Nicola Silvestris, Antonio Gnoni, Anna Elisabetta Brunetti, Leonardo Vincenti, Daniele Santini, Giuseppe Tonini, Francesca Merchionne, Evaristo Maiello, Vito Lorusso, Patrizia Nardulli, Amalia Azzariti and Michele Reni

Indometacin Ameliorates High Glucose-Induced Proliferation and Invasion Via Modulation of E-Cadherin in Pancreatic Cancer Cells

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 33
Page: 4142-4152
Authors: Liang Han, Bo Peng, Qingyong Ma, Jiguang Ma, Juntao Li, Wei Li, Wanxing Duan, Chao Chen, Jiangbo Liu, Qinhong Xu, Kyle Laporte, Zehui Li and Erxi Wu

Resveratrol Inhibits the Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells Via Suppression of the PI-3K/Akt/NF-κB Pathway

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 33
Page: 4185-4194
Authors: Wei Li, Jiguang Ma, Qingyong Ma, Bin Li, Liang Han, Jiangbo Liu, Qinhong Xu, Wanxing Duan, Shuo Yu, Fengfei Wang and Erxi Wu

Optimizing Gene Silencing Strategies for Pancreatic Cancer

Journal: Current Cancer Therapy Reviews
Volume: 9,Issue: 2
Page: 117-125
Authors: Ernest Ramsay Camp, Katie Hurst, Cindy Wang, David J. Cole and Dennis K. Watson

The Anti-Oxidant Properties of Isothiocyanates: A Review

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 7,Issue: 3
Page: 213-225
Authors: Sônia M. de Figueiredo, Sidney A.V. Filho, José A. Nogueira-Machado and Rachel B. Caligiorne

Farnesyltransferase Inhibitors: A Comprehensive Review Based on Quantitative Structural Analysis

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 38
Page: 4888-4923
Authors: N. S.H.N. Moorthy, S. F. Sousa, M. J. Ramos and P. A. Fernandes

Chemoprevention Gene Therapy (CGT) of Pancreatic Cancer Using Perillyl Alcohol and a Novel Chimeric Serotype Cancer Terminator Virus

Journal: Current Molecular Medicine
Volume: 14,Issue: 1
Page: 125-140
Authors: S. Sarkar, B. Azab, B.A. Quinn, X. Shen, P. Dent, A.L. Klibanov, L. Emdad, S.K. Das, D. Sarkar and P.B. Fisher

ZIP4 is a Novel Diagnostic and Prognostic Marker in Human Pancreatic Cancer: A Systemic Comparison Between EUS-FNA and Surgical Specimens

Journal: Current Molecular Medicine
Volume: 14,Issue: 3
Page: 309-315
Authors: C. Xu, M.B. Wallace, J. Yang, L. Jiang, Q. Zhai, Y. Zhang, C. Hong, Y. Chen, T.S. Frank, J.A. Stauffer, H.J. Asbun, M. Raimondo, T.A. Woodward, Z. Li, S. Guha, L. Zheng and M. Li

Systems Biology Approaches to Pancreatic Cancer Detection, Prevention and Treatment

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 1
Page: 73-80
Authors: Osama M. Alian, Philip A. Philip, Fazlul H. Sarkar and Asfar S. Azmi

Targeting miRNAs for Pancreatic Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 33
Page: 5279-5286
Authors: Min Shi, DachengXie, Yong Gaod and Keping Xie

Genistein Inhibits Cell Growth and Invasion Through Regulation of miR-27a in Pancreatic Cancer Cells

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 33
Page: 5348-5353
Authors: Jun Xia, Long Cheng, Chuanzhong Mei, Jia Ma, Ying Shi, Fanpeng Zeng, Zhenghuan Wang and Zhiwei Wang

Editorial (Thematic Issue: Advances with microRNAs in Tumorigenesis and Cancer Therapy)

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 33
Page: 5245-5245
Authors: Zhiwei Wang

Gemcitabine Resistance is Associated with Epithelial-Mesenchymal Transition and Induction of HIF-1α in Pancreatic Cancer Cells

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 4
Page: 407-417
Authors: Rui Wang, Long Cheng, Jun Xia, Zishu Wang, Qiong Wu and Zhiwei Wang

miR-1247 is Correlated with Prognosis of Pancreatic Cancer and Inhibits Cell Proliferation by Targeting Neuropilins

Journal: Current Molecular Medicine
Volume: 14,Issue: 3
Page: 316-327
Authors: S. Shi, Y. Lu, Y. Qin, W. Li, H. Cheng, Y. Xu, J. Xu, J. Long, L. Liu, C. Liu and X. Yu

Stathmin, Interacting with Nf-κB, Promotes Tumor Growth and Predicts Poor Prognosis of Pancreatic Cancer

Journal: Current Molecular Medicine
Volume: 14,Issue: 3
Page: 328-339
Authors: Y. Lu, C. Liu, H. Cheng, Y. Xu, J. Jiang, J. Xu, J. Long, L. Liu and X. Yu

Hyperglycemia Regulates TXNIP/TRX/ROS Axis via p38 MAPK and ERK Pathways in Pancreatic Cancer

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 4
Page: 348-356
Authors: Wei Li, Zheng Wu, Qingyong Ma, Jiangbo Liu, Qinhong Xu, Liang Han, Wanxing Duan, Yunfu Lv, Fengfei Wang, Katie M. Reindl and Erxi Wu

The Activation of β1-integrin by Type I Collagen Coupling with the Hedgehog Pathway Promotes the Epithelial-Mesenchymal Transition in Pancreatic Cancer

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 5
Page: 446-457
Authors: Wanxing Duan, Jiguang Ma, Qingyong Ma, Qinhong Xu, Jianjun Lei, Liang Han, Xuqi Li, Zheng Wang, Zheng Wu, Shifang Lv, Zhenhua Ma, Mouzhu Liu, Fengfei Wang and Erxi Wu

Fgf10: A Paracrine-Signaling Molecule in Development, Disease, and Regenerative Medicine

Journal: Current Molecular Medicine
Volume: 14,Issue: 4
Page: 504-509
Authors: N. Itoh and H. Ohta

Inhibition of Autophagy Strengthens Celastrol-Induced Apoptosis in Human Pancreatic Cancer In Vitro and In Vivo Models

Journal: Current Molecular Medicine
Volume: 14,Issue: 4
Page: 555-563
Authors: X. Zhao, S. Gao, H. Ren, H. Huang, W. Ji and J. Hao

Extracellular Superoxide and the Growth of Pancreatic Carcinoma

Journal: Current Cancer Therapy Reviews
Volume: 9,Issue: 4
Page: 278-283
Authors: John A. Cieslak and Joseph J. Cullen

Predicting Cancer-Related MiRNAs Using Expression Profiles in Tumor Tissue

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 5
Page: 438-444
Authors: Hsiuying Wang

Curcumin: A Promising Agent Targeting Cancer Stem Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 6
Page: 787-792
Authors: Shufei Zang, Tao Liu, Junping Shi and Liang Qiao

Eriocalyxin B-Induced Apoptosis in Pancreatic Adenocarcinoma Cells Through Thiol-Containing Antioxidant Systems and Downstream Signalling Pathways

Journal: Current Molecular Medicine
Volume: 14,Issue: 5
Page: 673-689
Authors: L. Li, G.G.L. Yue, J.X. Pu, H.D. Sun, K.P. Fung, P.C. Leung, Q.B. Han, C.B.S. Lau and P.S. Leung

SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 39
Page: 6182-6190
Authors: Jianguo Feng and Liling Tang

A Screening Method for Potential Anti-pancreatic Cancer Candidate Compounds Based on Hsp90-Cdc37 Interaction Model in vitro

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 1
Page: 66-71
Authors: Hai Zhang, Sen Sun, Qingshan Chen, Guoqing Zhang, Zhenqing Zhang, Duxin Sun and Wenpeng Zhang

Pancreatic Cancer: Systemic Combination Therapies for a Heterogeneous Disease

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 42
Page: 6660-6669
Authors: Davide Melisi, Lorenzo Calvetti, Melissa Frizziero and Giampaolo Tortora

Antiproliferative Effect of HSP90 Inhibitor Y306zh Against Pancreatic Cancer is Mediated by Interruption of AKT and MAPK Signaling Pathways

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 7
Page: 671-683
Authors: Nina Xue, Jing Jin, Di Liu, Rui Yan, Sen Zhang, Xiaoming Yu and Xiaoguang Chen

Chinese Medicine: A Novel Therapeutic Option for Pancreatic Cancer

Journal: Current Signal Transduction Therapy
Volume: 9,Issue: 1
Page: 26-31
Authors: Ping Yan, Yongxing Cao and Xiaotian Sun

Cholinergic Receptors as Target for Cancer Therapy in a Systems Medicine Perspective

Journal: Current Molecular Medicine
Volume: 14,Issue: 9
Page: 1126-1138
Authors: P. Russo, A. Del Bufalo, M. Milic, G. Salinaro, M. Fini and A. Cesario

The Mediterranean Diet and Gastrointestinal Cancers Risk

Journal: Recent Patents on Food, Nutrition & Agriculture
Volume: 6,Issue: 1
Page: 23-26
Authors: Qianxin Wang, Jianpeng Hao, Quanlin Guan and Wenzhen Yuan

Targeting c-MET/HGF Signaling Pathway in Upper Gastrointestinal Cancers: Rationale and Progress

Journal: Current Drug Targets
Volume: 15,Issue: 14
Page: 1302-1311
Authors: Sharareh Gholamin, Hamid Fiuji, Mina Maftouh, Reza Mirhafez, Fatemeh Homaei Shandiz and Amir Avan

EGFR as a Potential Target for the Treatment of Pancreatic Cancer: Dilemma and Controversies

Journal: Current Drug Targets
Volume: 15,Issue: 14
Page: 1293-1301
Authors: Reza Nedaeinia, Amir Avan, Mostafa Manian, Rasoul Salehi and Majid Ghayour-Mobarhan

Review and Research Analysis of Computational Target Methods Using BioRuby and In silico Screening of Herbal Lead Compounds Against Pancreatic Cancer Using R Programming

Journal: Current Drug Metabolism
Volume: 15,Issue: 5
Page: 535-543
Authors: Jayadeepa R.M, Ankita Ray, Dhaval Naik, Debendra Nath Sanyal and Disha Shah

Matrix Metalloproteinase Inhibitor MMI-166 Suppresses the Growth of SW1990 Human Pancreatic Cancer Cells

Journal: Current Signal Transduction Therapy
Volume: 9,Issue: 2
Page: 93-100
Authors: Junben Wu, Muhammad Shahbaz, Shujing Wang, Bengang Gong, Benjia Liang, Ruliang Fang, Bo Qiu, Min Jiang, Yang Li and Jun Niu

Signal Transduction Therapy in Pancreatic Cancer

Journal: Current Signal Transduction Therapy
Volume: 9,Issue: 2
Page: 78-82
Authors: Xiaotian Sun, Zhaoshen Li and Min Li

Pancreatic Cancer Metastasis: Are we being Pre-EMTed?

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 10
Page: 1249-1255
Authors: Srustidhar Das and Surinder K. Batra

Vitamin D Receptor Signaling and Pancreatic Cancer Cell EMT

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 10
Page: 1262-1267
Authors: Zhiwei Li, Junli Guo, Keping Xie and Shaojiang Zheng

NMR-based Metabolite Profiling of Pancreatic Cancer

Journal: Current Metabolomics
Volume: 2,Issue: 3
Page: 204-212
Authors: Kwadwo Owusu-Sarfo, Vincent M. Asiago, Lingli Deng, Haiwei Gu, Siwei Wei, Narasimhamurthy Shanaiah, G. A. Nagana Gowda, Bowei Xi, Elena G. Chiorean and Daniel Raftery

FBP1, A Tumor Suppressor and Negative Regulator of Glycolysis, was Epigenetically Silenced in Pancreatic Cancer

Journal: Current Signal Transduction Therapy
Volume: 9,Issue: 3
Page: 156-163
Authors: Bo Zhang, Yi Qin, Si Shi, Shunrong Ji, Wenyan Xu, Jiang Liu, Jiang Long, Chen Liu, Liang Liu, Quanxing Ni, Jin Xu and Xianjun Yu

5-Lipoxygenase and Cyclooxygenase Inhibitory Dammarane Triterpenoid 1 from Borassus flabellifer Seed Coat Inhibits Tumor Necrosis Factor-α Secretion in LPSInduced THP-1 Human Monocytes and Induces Apoptosis in MIA PaCa-2 Pancreatic Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 8
Page: 1066-1077
Authors: Nagendra Sastry Yarla, Rajaram Azad, Mahaboob Basha, Abdul Rajack, D. S. V. G. K. Kaladhar, Bharat Kumar Allam, Rajeswara Rao. Pragada, Krishna Nand Singh, Sunanda Kumari K, Reddanna Pallu, Umadevi Parimi, Anupam Bishayee and Govinda Rao. Duddukuri

Synthesis, Spectral Characterization and Anticancer Activity of New 2,3,6- Substituted Quinazolin-4(3H)-one Derivatives

Journal: Letters in Organic Chemistry
Volume: 12,Issue: 6
Page: 385-393
Authors: Peddakonda Ramesh, Doddaga Srinivasulu, Polireddy Kishore, Valasani Koteswara Rao and Muttana Vijaya Bhaskara Reddy

Gemcitabine Plus Nab-Paclitaxel as Second-Line and Beyond Treatment for Metastatic Pancreatic Cancer: a Single Institution Retrospective Analysis

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 2
Page: 142-145
Authors: Paola Bertocchi, Chiara Abeni, Fausto Meriggi, Luigina Rota, Anna Rizzi, Brunella Di Biasi, Francesca Aroldi, Chiara Ogliosi, Giordano Savelli, Edoardo Rosso and Alberto Zaniboni

Development of Hedgehog Pathway Inhibitors (HPI) in Treatment of Cancer

Journal: Current Chemical Biology
Volume: 8,Issue: 3
Page: 132-148
Authors: Dipankar Pramanik

A Personalized Approach to Systemic Treatment of Unresectable or Metastatic Pancreatic Adenocarcinoma

Journal: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)
Volume: 12,Issue: 4
Page: 188-198
Authors: Jacob Frick and Tomislav Dragovich

Synthesis of Dichlorophenyl-, Cyanophenyl- and Quinolinyl-Substituted

Journal: Letters in Organic Chemistry
Volume: 12,Issue: 6
Page: 407-412
Authors: Clare E. Gutteridge, Sean M. Curtis, Joshua W. Major, Daniel A. Nin, Apurba K. Bhattacharjee, Daniel A. Nichols and Lucia Gerena

miRNA-101 Suppresses Epithelial-to-mesenchymal Transition by Targeting HMGA2 in Pancreatic Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 4
Page: 432-439
Authors: Wenli Jiang, Wen Gu, Ronglin Qiu, Songbing He, Chenglong Shen, Yaohao Wu, Jie Zhang, Jiajia Zhou, Yixing Guo, Daiwei Wan, Zhixi Li, Jiemin Deng, Lexiang Zeng, Jin Tang, Jin Zhou, Qiaoming Zhi and Xiaogeng Deng

Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 6
Page: 463-468
Authors: Marc Giry-Laterriere, Andreia V. Pinho, Nils Eling, Lorraine Chantrill and Ilse Rooman

Cyclophilin function in Cancer; lessons from virus replication

Journal: Current Molecular Pharmacology
Volume: 9,Issue: 2
Page: 148-164
Authors: Paul T.M. Lavin and Margaret M. Mc Gee

Promotion of Metastasis-associated Gene Expression in Survived PANC-1 Cells Following Trichostatin A Treatment

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 10
Page: 1317-1325
Authors: Zongjing Chen, Yunxiu Yang, Biao Liu, Benquan Wang, Meng Sun, Ling Zhang, Bicheng Chen, Heyi You and Mengtao Zhou


Improving Image Quality of Pancreatic Cancer and Surrounding Vessels with Spectral CT Imaging

Journal: Current Medical Imaging Reviews
Volume: 11,Issue: 3
Page: 185-191
Authors: Qi Miao, Xiaoling Li, Ke Ren, Yu Zhao, Li Zhao and Ke Xu

FoxQ1 is a Novel Molecular Target for Pancreatic Cancer and is Associated with Poor Prognosis

Journal: Current Molecular Medicine
Volume: 15,Issue: 5
Page: 469-477
Authors: H. -X. Zhan, J. -W. Xu, L. Wang, D. Wu, G. -Y. Zhang and S. -Y. Hu

Treatment of Pancreatic Cancer with Pharmacological Ascorbate

Journal: Current Pharmaceutical Biotechnology
Volume: 16,Issue: 9
Page: 759-770
Authors: John A. Cieslak and Joseph J. Cullen

Thymoquinone Anticancer Discovery: Possible Mechanisms

Journal: Current Drug Discovery Technologies
Volume: 12,Issue: 2
Page: 80-89
Authors: Ali H. El-Far

Current and Future Trends in Early Detection of Pancreatic Cancer: Molecular Targets and PET Probes

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 29
Page: 3370-3389
Authors: Mian M. Alauddin and Louis De Palatis

Multiple Pharmacological Properties of a Novel Parthenin Analog P16 as Evident by its Cytostatic and Antiangiogenic Potential Against Pancreatic Adenocarcinoma PANC -1 Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 6
Page: 771-780
Authors: Akshra Goswami, Bhahwal Ali Shah, Navneet Batra, Ajay Kumar, Santosh Kumar Guru, Shashi Bhushan, Fayaz Ahmad Malik, Amit Joshi and Jagtar Singh

Immune Therapy in Pancreatic Cancer: Now and the Future?

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 4
Page: 317-325
Authors: Yue Zhang and Minsig Choi

Pancreatic Cancer: Promises and Failures of Target Therapies

Journal: Reviews on Recent Clinical Trials
Volume: 11,Issue: 1
Page: 33-38
Authors: Francesca Aroldi, Paola Bertocchi, Edoardo Rosso, Tiziana Prochilo and Alberto Zaniboni

How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16,Issue: 5
Page: 358-369
Authors: Ethan J. Brock, Kyungmin Ji, John J. Reiners and Raymond R. Mattingly

Current Systemic Treatment and Emerging Therapeutic Strategies in Pancreatic Adenocarcinoma

Journal: Current Clinical Pharmacology
Volume: 10,Issue: 4
Page: 256-266
Authors: Nelson S. Yee, Abid A. Kazi and Rosemary K. Yee

Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Clinical Update of Safety and Efficacy

Journal: Current Diabetes Reviews
Volume: 12,Issue: 4
Page: 403-413
Authors: Scott R. Drab

Infectivity Selective Adenovirus Based on High-throughput Adenoviral Ligand Library Screening

Journal: Current Cancer Therapy Reviews
Volume: 11,Issue: 3
Page: 154-162
Authors: Masato Yamamoto

Clinical Significance of Mesothelin in Pancreatic Cancer

Journal: Current Signal Transduction Therapy
Volume: 11,Issue: 1
Page: 9-12
Authors: Lei Zhang, Xiaoling Ni and Dayong Jin

VEGF Promotes Glycolysis in Pancreatic Cancer via HIF1α Up-Regulation

Journal: Current Molecular Medicine
Volume: 16,Issue: 4
Page: 394-403
Authors: S. Shi, J. Xu, B. Zhang, S. Ji, W. Xu, J. Liu, K. Jin, D. Liang, C. Liang, L. Liu, C. Liu, Y. Qin and X. Yu

MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer

Journal: Current Molecular Medicine
Volume: 16,Issue: 4
Page: 404-411
Authors: B. Zhang, J. Xu, C. Li, S. Shi, S. Ji, W. Xu, J. Liu, K. Jin, D. Liang, C. Liang, L. Liu, C. Liu, Y. Qin and X. Yu

The Role of Stromal Components in Pancreatic Cancer Progression

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 9
Page: 1117-1124
Authors: Mengdan Xu, Binhua P. Zhou, Min Tao, Jingyi Liu and Wei Li

Current Role of Proteomics in Pancreatic Cancer Biomarkers Research

Journal: Current Proteomics
Volume: 13,Issue: 1
Page: 68-75
Authors: Audrius Sileikis, Marius Petrulionis, Benediktas Kurlinkus, Marija Ger, Algirdas Kaupinis, Jonas Cicenas, Mindaugas Valius and Kestutis Strupas

Phytochemicals and Cancer Stem Cells: A Pancreatic Cancer Overview

Journal: Current Chemical Biology
Volume: 10,Issue: 2
Page: 98-108
Authors: Suvroma Gupta and Dipankar Pramanik

Design and Synthesis of Curcumin-Like Diarylpentanoid Analogues as Potential Anticancer Agents

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11,Issue: 3
Page: 342-351
Authors: Elahe Qudjani, Maryam Iman, Asghar Davood, Mahdi F. Ramandi and Abbas Shafiee

Plant Derived Inhibitor Sulforaphane in Combinatorial Therapy Against Therapeutically Challenging Pancreatic Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 3
Page: 365-373
Authors: Shabir Ahmad Ganai, Romana Rashid, Ehsaan Abdullah and Mohammad Altaf

Pancreatic Neoplasms and Autophagy

Journal: Current Drug Targets
Volume: 19,Issue: 9
Page: 1018-1023
Authors: Linzi A. Barton and Jun Ren*

Induction of Autophagic Cell Death in Apoptosis-resistant Pancreatic Cancer Cells using Benzo[α]phenoxazines Derivatives, 10-methyl-benzo[α]phenoxazine-5-one and benzo[α]phenoxazine-5-one

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 1
Page: 115-125
Authors: Sanjima Pal, Sunita Salunke-Gawalib and V. Badireenath Konkimallaa

Liposomal Irinotecan in the Treatment of Refractory Pancreatic Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11,Issue: 4
Page: 376-383
Authors: Harold Bien, Gerardo G. Mackenzie and Minsig Choi

Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 42
Page: 6444-6450
Authors: Safieh Ebrahimi, Mina Hosseini, Faezeh Ghasemi, Soodabeh Shahidsales, Mina Maftouh, Hamed Akbarzade, Seyed Ali Reza Parizadeh, Seyed Mahdi Hassanian and Amir Avan

Long Non-Coding RNA: An Emerging Paradigm of Pancreatic Cancer

Journal: Current Molecular Medicine
Volume: 16,Issue: 8
Page: 702-709
Authors: T. Han, H. Hu, M. Zhuo, L. Wang, J.-J. Cui, F. Jiao and L.-W. Wang

EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 1
Page: 89-97
Authors: Chenfei Zhou, Liangjun Zhu, Jun Ji, Fangmi Ding, Chao Wang, Qu Cai, Yingyan Yu, Zhenggang Zhu and Jun Zhang

Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 22
Page: 2585-2594
Authors: Dharmalingam Subramaniam, Gaurav Kaushik, Prasad Dandawate and Shrikant Anant*

Pancreatic Cancer Therapy Review: From Classic Therapeutic Agents to Modern Nanotechnologies

Journal: Current Drug Metabolism
Volume: 18,Issue: 4
Page: 346-359
Authors: Ana Rebelo, Jesus Molpeceres, Patrícia Rijo and Catarina Pinto Reis

Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 13
Page: 1321-1331
Authors: Safieh Ebrahimi, Mina Hosseini, Soodabeh Shahidsales, Mina Maftouh, Gordon A. Ferns, Majid Ghayour-Mobarhan, Seyed Mahdi Hassanian* and Amir Avan*

The Role of Target Therapy in the Treatment of Gastrointestinal Noncolorectal Cancers: Clinical Impact and Cost Consideration

Journal: Current Cancer Drug Targets
Volume: 18,Issue: 5
Page: 430-441
Authors: Massimiliano Berretta*, Carmela Romano, Raffaele Di Francia, Chiara De Diviitis, Vincenzo Canzonieri, Michele Caraglia, Gaetano Facchini and Guglielmo Nasti

Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 22
Page: 2535-2544
Authors: Altaf Mohammed*, Naveena B. Janakiram, Venkateshwar Madka, Min Li, Adam S. Asch and Chinthalapally V. Rao*

The Development of Oncoltyic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer

Journal: Current Cancer Drug Targets
Volume: 18,Issue: 2
Page: 153-161
Authors: Mizuho Sato-Dahlman and Masato Yamamoto*

Immunoprevention of Pancreatic Cancer

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 22
Page: 2576-2584
Authors: Chinthalapally V. Rao, Altaf Mohammed, Adam S. Asch and Naveena B. Janakiram*

Regulatory Role of G Protein-coupled Receptors in Pancreatic Cancer Development and Progression

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 22
Page: 2566-2575
Authors: Hildegard M. Schuller*

Natural Anti-Cancer Agents: Implications in Gemcitabine-Resistant Pancreatic Cancer Treatment

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17,Issue: 11
Page: 920-927
Authors: Bishal Marasini and Ravi P. Sahu*

Effect and Mechanism of Curcumin on EZH2 - miR-101 Regulatory Feedback Loop in Multiple Myeloma

Journal: Current Pharmaceutical Design
Volume: 24,Issue: 5
Page: 564-575
Authors: Chuanqing Wu, Tuo Ruan, Weizhen Liu, Xiaojie Zhu, Juan Pan, Wen Lu, Chen Yan, Kaixiong Tao , Weikang Zhang* and Chun Zhang*

Mechanisms and Drug Targets for Pancreatic Cancer Chemoprevention

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 22
Page: 2545-2565
Authors: Deepanshi Dhar, Komal Raina and Rajesh Agarwal*

Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 22
Page: 2595-2607
Authors: Jian-Yu E, Judith M. Graber, Shou-En Lu, Yong Lin, Grace Lu-Yao and Xiang-Lin Tan*

Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 32
Page: 3485-3507
Authors: Byron J. Aguilar*, Huchen Zhou and Qun Lu *

The Complexity of Omega-3 Fatty Acid Modulation of Signaling Pathways Related to Pancreatic Cancer

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 22
Page: 2608-2623
Authors: Carolina Torres, Andrew M. Diaz, Daniel R. Principe and Paul J. Grippo*

PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials

Journal: Current Drug Targets
Volume: 19,Issue: 1
Page: 21-37
Authors: Dalia Kamel*, Christopher Gray, Jagdeep Singh Walia and Vikaash Kumar*

Emerging Molecular Targets for Anti-Cancer Drug Design

Journal: Current Chemical Biology
Volume: 12,Issue: 1
Page: 88-99
Authors: Rohit Dutt, Vandana Garg and Anil K. Madan*

Design, Synthesis and In vitro Evaluation of Piperazine Incorporated Novel Anticancer Agents

Journal: Letters in Drug Design & Discovery
Volume: 15,Issue: 8
Page: 866-874
Authors: Mahaveer Singh*, Hemant R. Jadhav* and Amit Kumar

Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18,Issue: 3
Page: 375-387
Authors: Hassiba Rouibah, Wided Kebsa, Mesbah Lahouel*, Malek Zihlif, Mamoun Ahram, Bachaer Aburmeleih, Ebtihal Mustafa and Hemzeh El-Amir

The Role of Stereotactic Body Radiation Therapy in Pancreatic Cancer

Journal: Current Cancer Therapy Reviews
Volume: 14,Issue: 1
Page: 46-54
Authors: Priscilla K. Stumpf and Karyn A. Goodman*

New Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18,Issue:
Page: 1-9
Authors: Leyla Yurttas* and Gulsen Akalin Ciftci

Neoadjuvant Therapy is Essential for Resectable Pancreatic Cancer

Journal: Current Medicinal Chemistry
Volume: 25,Issue:
Page: 1-15
Authors: Jin-Zhi Xu, Wen-Quan Wang, Shi-Rong Zhang, Hua-Xiang Xu, Chun-Tao Wu, Zi-Hao Qi, He-Li Gao, Shuo Li, Quan-Xing Ni, Xian-Jun Yu and Liang Liu*

Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells

Journal: Current Cancer Drug Targets
Volume: 18,Issue:
Page: 1-11
Authors: Xiang Chen, Jilai Tian, Gloria H. Su and Jiayuh Lin*

Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models

Journal: Clinical Cancer Drugs
Volume: 5,Issue:
Page: 1-8
Authors: Anna R. Schreiber, Anna Nguyen, Stacey M. Bagby, John J. Arcaroli, Betelehem Yacob, Kevin Quackenbush, Joe L. Guy, Thomas Crowell, Bradley Stringer, Hadi Danaee, Thea Kalebic, Wells A. Messersmith and Todd M. Pitts

Risk and Benefit Profile of Dulaglutide in Established Therapeutic Indication

Journal: Current Drug Safety
Volume: 13,Issue:
Page: 1-6
Authors: Aakriti Garg and Anoop Kumar*

Pancreatic Cancer Chemoprevention: Challenges and Opportunities

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 22
Page: 2532-2534
Authors: Altaf Mohammed and Chinthalapally V. Rao